Published in Acta Oncol on January 01, 1992
Selective estrogen receptor modulators: tissue specificity and clinical utility. Clin Interv Aging (2014) 0.88
Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet (1995) 3.03
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Cancer patients use of nonproven therapy: a 5-year follow-up study. J Clin Oncol (1998) 2.05
Testicular cancer treated in a minor general oncology department. Eur J Cancer (1995) 2.03
Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. Am J Hum Genet (1997) 1.94
Distribution of 4-hydroxy-N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment. Cancer Res (1989) 1.91
High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy. Breast Cancer Res Treat (2001) 1.88
Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat (1999) 1.63
The level of physical activity in long-term survivors of testicular cancer. Eur J Cancer (2003) 1.61
The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer (1995) 1.56
The effect of aphidicolin on DNA synthesis in isolated HeLa cell nuclei. Nucleic Acids Res (1979) 1.55
Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer. N Engl J Med (1990) 1.48
Identification of 4-hydroxy-N-desmethyltamoxifen as a metabolite of tamoxifen in human bile. Cancer Res (1988) 1.45
Clinical evaluation of C-Film, a vaginal contraceptive. J Int Med Res (1975) 1.41
[Accidents with radioactive pollution. Can we do something?]. Tidsskr Nor Laegeforen (1992) 1.40
[Testicular cancer treated at the regional hospital in Tromsø 1985-1993]. Tidsskr Nor Laegeforen (1995) 1.40
[Is comorbidity a prognostic factor in premenopausal women with breast cancer?]. Tidsskr Nor Laegeforen (2001) 1.39
Follow-up of breast cancer patients stage I-II: a baseline strategy. Eur J Cancer (1993) 1.39
Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. 1996. Int J Hyperthermia (2009) 1.39
Body mass index and risk of breast cancer. A prospective study of 23,826 Norwegian women. Int J Cancer (1990) 1.34
CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. AJNR Am J Neuroradiol (2009) 1.30
Psychological distress in cancer patients with advanced disease. Radiother Oncol (1993) 1.28
Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study. Clin Cancer Res (1997) 1.22
Improved measurement of androgen receptors in human breast cancer. Cancer Res (1989) 1.20
Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia (1996) 1.18
Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II Study. Eur J Cancer (1997) 1.18
Aphidicolin inhibits DNA synthesis by DNA polymerase alpha and isolated nuclei by a similar mechanism. Nucleic Acids Res (1981) 1.16
Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. Eur J Surg Oncol (1992) 1.15
The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas. Eur J Cancer Clin Oncol (1987) 1.14
Widowhood and divorce related to cancer risk in middle-aged women. A nested case-control study among Norwegian women born between 1935 and 1954. Int J Cancer (1994) 1.12
Body height and risk of breast cancer. A prospective study of 23,831 Norwegian women. Br J Cancer (1990) 1.11
Accumulation of small fragments of DNA in isolated HeLa cell nuclei due to transient incorporation of dUMP. Biochim Biophys Acta (1978) 1.09
Superparamagnetic iron oxide nanoparticles in biomedicine: applications and developments in diagnostics and therapy. Rofo (2013) 1.09
Death of a husband or marital divorce related to risk of breast cancer in middle-aged women. A nested case-control study among Norwegian women born 1935-1954. Eur J Cancer (1994) 1.07
1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed (1994) 1.07
Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter study. Anticancer Res (2000) 1.06
Knowledge of and attitudes toward complementary and alternative therapies; a national multicentre study of oncology professionals in Norway. Eur J Cancer (2004) 1.05
Relationship of cyclic AMP binding capacity and estrogen receptor to hormone sensitivity in human breast cancer. Breast Cancer Res Treat (1983) 1.02
Lumbar epidural analgesia in labour. I. Acid-base balance and clinical condition of mother, fetus and newborn child. Acta Obstet Gynecol Scand (1974) 1.02
Health technology assessment and implications for clinical practice: the case of prostate cancer screening. Scand J Clin Lab Invest (2003) 1.00
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients. Br J Cancer (2005) 1.00
Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer. Drugs (1988) 0.99
Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer. Clin Cancer Res (2000) 0.99
In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue. Anticancer Res (1994) 0.99
Prognostic factors and survival in a heterogeneous sample of cancer patients. Br J Cancer (1996) 0.98
Consequences of local recurrence of soft tissue sarcoma: 205 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand (2000) 0.98
Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced disease. Br J Cancer (1987) 0.97
Overall survival of breast cancer patients in relation to preclinically determined total serum cholesterol, body mass index, height and cigarette smoking: a population-based study. Eur J Cancer (1991) 0.97
Effect of cytosol on DNA synthesis in isolated HeLa cell nuclei. Biochem Biophys Res Commun (1977) 0.96
Potential of information technology in dental education. Eur J Dent Educ (2008) 0.94
A mental route to motor learning: improving trajectorial kinematics through imagery training. Behav Brain Res (1998) 0.94
Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway. Eur J Cancer (1997) 0.94
The leucocyte nadir, a predictor of chemotherapy efficacy? Br J Cancer (1999) 0.94
Aminoglutethimide and warfarin. A new important drug interaction. Cancer Chemother Pharmacol (1984) 0.93
Pregnancy-related factors and risk of breast cancer in a prospective study of 29,981 Norwegian women. Eur J Cancer (1992) 0.93
Oestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods. J Clin Pathol (1992) 0.93
Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo. Cancer Res (1986) 0.92
Per- and postoperative changes in coagulation and fibrinolytic variables during abdominal hysterectomy under epidural or general anaesthesia. Acta Anaesthesiol Scand (1986) 0.91
Preservation by glycerol of DNA synthetic capacity of isolated HeLa S(3) cell nuclei during long term storage at low temperature. Exp Cell Res (1978) 0.91
Alterations in the metabolism of oestrogens during treatment with aminoglutethimide in breast cancer patients. Preliminary findings. Clin Pharmacokinet (1987) 0.91
Adjuvant endocrine treatment (goserelin vs tamoxifen) in pre-menopausal patients with operable node positive stage II breast cancer. A prospective randomized national multicenter study. Eur J Surg Oncol (2002) 0.90
Prospective study of height, body mass index and risk of breast cancer. Acta Oncol (1992) 0.90
Does early physical maturity influence breast cancer risk? Acta Oncol (1994) 0.90
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial. Eur J Cancer (1998) 0.89
Interethnic difference in thiopurine methyltransferase activity. Clin Pharmacol Ther (1992) 0.89
Melphalan uptake in relation to vascular and extracellular space of human lung-tumour xenografts. Br J Cancer (1981) 0.89
Regression analyses of prognostic factors in metastatic malignant melanoma. Eur J Cancer Clin Oncol (1989) 0.89
Quality assurance and benchmarking: an approach for European dental schools. Eur J Dent Educ (2007) 0.88
Weekly adriamycin versus VAC in advanced breast cancer. A randomized trial. Eur J Cancer Clin Oncol (1986) 0.87
Plasma changes in breast cancer patients during endocrine therapy--lipid measurements and nuclear magnetic resonance (NMR) spectroscopy. Breast Cancer Res Treat (1995) 0.87
Cigarette smoking and risk of breast cancer: a prospective study of 24,329 Norwegian women. Eur J Cancer (1990) 0.87
DNA replication intermediates in whole HeLa cells and isolated nuclei. Biochim Biophys Acta (1977) 0.87
Lumbar epidural analgesia with bupivacaine in labor. Drug concentration in maternal and neonatal blood at birth and during the first day of life. Am J Obstet Gynecol (1975) 0.87
Progesterone-binding cyst protein in human breast tumor cytosol. Cancer Res (1987) 0.87
Performance, mood, and clinical symptoms in men exposed to prolonged, severe physical work and sleep deprivation. Aviat Space Environ Med (1978) 0.87
Primary retroperitoneal sarcomas. A review of 36 cases. Acta Radiol Oncol (1985) 0.87
Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy. Ann Oncol (2007) 0.87
Effect of 1-beta-D-arabinofuranosylcytosine triphosphate on DNA synthesis in isolated HeLa cell nuclei. Biochemistry (1976) 0.86
Use of complementary and alternative therapies: a national multicentre study of oncology health professionals in Norway. Support Care Cancer (2004) 0.86
Clinical pharmacokinetics of endocrine agents used in advanced breast cancer. Clin Pharmacokinet (1992) 0.86
Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography. J Magn Reson Imaging (1994) 0.85
Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer. Eur J Cancer (1997) 0.85
Partial resection of the cartilaginous nasal septum in rats; its influence on growth. Angle Orthod (1974) 0.85
Circulating anodic antigen (CAA) levels in different age groups in a Zimbabwean rural community endemic for Schistosoma haematobium determined using the magnetic beads antigen-capture enzyme-linked immunoassay. Am J Trop Med Hyg (1996) 0.85
Epithelial restitution and cellular proliferation after gastric mucosal damage caused by hypertonic NaCl in rats. Virchows Arch A Pathol Anat Histopathol (1988) 0.85
The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study. Eur J Cancer (1995) 0.84
Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanoma. Invest New Drugs (1990) 0.84
Protein kinases activated by cAMP in the genital tract of spayed mice treated with oestradiol-17beta. J Reprod Fertil (1975) 0.84
Lumbar epidural analgesia with bupivacaine in labor. Determination of drug concentration and pH in fetal scalp blood, and continuous fetal heart rate monitoring. Am J Obstet Gynecol (1975) 0.84
Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population. Eur J Clin Pharmacol (1993) 0.84
Status of clinical hyperthermia. Acta Oncol (1999) 0.83
Quality of life of cancer patients with different prognoses. Qual Life Res (1994) 0.83